Antitumor effect and its molecular mechanism of artemisinin and its derivatives

doi:10.3760/cma.j.issn.1673422X.2016.12.012

Abstract

Abstract: Artemisinin and its derivatives are the first choices for the treatment of malaria medicine. In recent years, a large number of studies in vivo and in vitro show that artemisinin and its derivatives have good antitumor activities. Its antitumor mechanism mainly includes the oxidation damage reaction, inhibiting tumor cell proliferation and resistance to new angiogenesis. Artemisinin and its derivatives have little side effect, low cost, effective aginst multidrugresistant cell and a synergistic effect on radiotherapy and chemotherapy, which may become promising clinical anticancer compounds.

Key words: Artemisinin, Antineoplastic agents, Molecular mechanisms of pharmacological action

XIN Zhong-Yang, WANG Bao-Cheng, WANG Jun. Antitumor effect and its molecular mechanism of artemisinin and its derivatives[J]. Journal of International Oncology, 2016, 43(12): 927-929.

References

［1］ White NJ, Hien TT, Nosten FH. A brief history of Qinghaosu［J］. Trends Parasitol, 2015, 31(12): 607610. DOI: 10.1016/j.pt.2015.10.010. ［2］ CrespoOrtiz MP, Wei MQ. Antitumor activity of artemisinin and its derivatives: from a wellknown antimalarial agent to a potential anticancer drug［J］. J Biomed Biotechnol, 2012, 2012: 247597. DOI: 10.1155/2012/247597. ［3］ Tan W, Lu J, Huang M, et al. Anticancer natural products isolated from chinese medicinal herbs［J］. Chin Med, 2011, 6(1): 27. DOI: 10.1186/17498546627. ［4］ Du JH, Zhang HD, Ma ZJ, et al. Artesunate induces oncosislike cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo［J］. Cancer Chemother Pharmacol, 2010, 65(5): 895902. DOI: 10.1007/s0028000910955. ［5］ Ho WE, Peh HY, Chan TK, et al. Artemisinins: pharmacological actions beyond antimalarial［J］. Pharmacol Ther, 2014, 142(1): 126139. DOI: 10.1016/j.pharmthera.2013.12.001. ［6］ Yan X, Yu Y, Ji P, et al. Antitumor activity of endoperoxideiron chelator conjugatesdesign, synthesis and biological evaluation［J］. Eur J Med Chem, 2015, 102: 180187. DOI: 10.1016/j.ejmech.2015.07.040. ［7］ Beekman AC, Wierenga PK, Woerdenbag HJ, et al. Artemisininderived sesquiterpene lactones as potential antitumour compounds: cytotox action against bone marrow and tumour cells［J］. Planta Med, 1998, 64(7): 615619. ［8］ Mercer AE, Maggs JL, Sun XM, et al. Evidence for the involvement of carboncentered radicals in the induction of apoptotic cell death by artemisinin compounds［J］. J Biol Chem, 2007, 282(13): 93729382. ［9］ Mercer AE, Copple IM, Maggs JL, et al. The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials［J］. J Biol Chem, 2011, 286(2): 987996. ［10］ Yang Y, Zhang X, Wang X, et al. Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin ［J］. Int J Pharm, 2014, 467(12): 113122. ［11］ Michaelis M, Kleinschmidt MC, Barth S, et al. Anticancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines［J］. Biochem Pharmacol, 2010, 79(2): 130136. DOI: 10.1016/j.bcp.2009.08.013. ［12］ Zhao F, Wang H, Kunda P, et al. Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71［J］. Oncol Rep, 2013, 30(3): 14731482. DOI: 10.3892/or.2013.2574. ［13］ Wang SJ, Gao Y, Chen H, et al. Dihydroartemisinin inactivates NFkappaB and potentiates the antitumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo［J］. Cancer Lett, 2010, 293(1): 99108. DOI: 10.1016/j.canlet.2010.01.001. ［14］ Zhang HT, Wang YL, Zhang J, et al. Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53［J］. Tumour Biol, 2014, 35(2): 14031409. ［15］ Mondal A, Chatterji U. Artemisinin represses telomerase subunits and induces apoptosis in HPV39 infected human cervical cancer cells［J］. J Cell Biochem, 2015, 116(9): 19681981. DOI: 10.1002/jcb.25152. ［16］ Xu Q, Li ZX, Peng HQ, et al. Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo［J］. J Zhejiang Univ Sci B, 2011, 12(4): 247255. ［17］ Lu M, Sun L, Zhou J, et al. Dihydroartemisinin induces apoptosis in colorectal cancer cells through the mitochondriadependent pathway［J］. Tumour Biol, 2014, 35(6): 53075314. DOI: 10.1007/s1327701416919. ［18］ He Q, Shi J, Shen XL, et al. Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells［J］. Cancer Biol Ther, 2010, 9(10): 819824. ［19］ Mi YJ, Geng GJ, Zou ZZ, et al. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in nonsmall cell lung carcinoma cells［J］. PLoS One, 2015, 10(3): e0120426. DOI: 10.1371/journal.pone.0120426. ［20］ Zhang JL, Wang Z, Hu W, et al. DHA regulates angiogenesis and improves the efficiency of CDDP for the treatment of lung carcinoma［J］. Microvasc Res, 2013, 87: 1424. DOI: 10.1016/j.mvr.2013.02.006. ［21］ Wang SJ, Sun B, Cheng ZX, et al. Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NFκB pathway［J］. Cancer Chemother Pharmacol, 2011, 68(6): 14211430. DOI: 10.1007/s0028001116437.

[1]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[2]	Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan. Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity， proliferation， and apoptosis of multiple myeloma cells [J]. Journal of International Oncology, 2024, 51(3): 129-136.
[3]	Wang Liwei, Liang Hongsheng, Du Songlin, Chen Zhihao, Wang Qing, Gao Aili. Research progress of avermectins in anti-tumor [J]. Journal of International Oncology, 2022, 49(6): 353-356.
[4]	Wang Shuang, Tang Yunyun, Yue Qi. New progress in antitumor research of non-psychoactive cannabidiol [J]. Journal of International Oncology, 2020, 47(10): 619-623.
[5]	Yi Lin, Qiu Shi. Anti-tumor effect and mechanisms of shikonin on gliomas [J]. Journal of International Oncology, 2019, 46(8): 489-491.
[6]	Liang Jing1,3, Han Sha2, Yao Jing3, Kong Qingsheng2. Effect of histone deacetylase and its inhibitor on tumor [J]. Journal of International Oncology, 2019, 46(4): 235-238.
[7]	Xiong Bobo, Zhang Jinsong, Li Ning, Wang Haifeng, Zuo Yigang, Wang Jiansong. Molecular targeted therapy for advanced kidney cancer [J]. Journal of International Oncology, 2019, 46(12): 705-710.
[8]	Wang Gang, Wang Huangzhen, Xue Ting. Effect of oxaliplatin induced autophagy on drug resistance of SGC7901 gastric cancer cells [J]. Journal of International Oncology, 2018, 45(8): 513-518.
[9]	Ling Xiaofei, Xu Ke, Shao Hua, Wang Cuijuan. Anticancer mechanism and application of curcumin analog EF24 [J]. Journal of International Oncology, 2018, 45(3): 172-175.
[10]	Liang Biyu, He Weiming, He Xiaoyi, Ding Yuanlin, Yu Haibing. Diabetes, hypoglycemic drugs and pancreatic cancer [J]. Journal of International Oncology, 2018, 45(3): 183-186.
[11]	QIU Mei-Qing, WANG Tao, TONG Zhong-Sheng, JIA Yong-Sheng. Effects and mechanism of overexpression of Mfn2 gene on photodynamic therapy sensitivity of T47D cells in human breast cancer [J]. Journal of International Oncology, 2017, 44(8): 641-646.
[12]	Peng Wenmiao, Fu Hongxing, Yu Lifang, Rao Zhiguo. Mechanism of anti-tumor effect of dihydroartemisinin [J]. Journal of International Oncology, 2017, 44(6): 448-.
[13]	Chen Gang, Zhuang Fangcheng. High mobility group box 1 and its role in cervical cancer [J]. Journal of International Oncology, 2017, 44(3): 235-238.
[14]	Dong Yi, Wei Yuehua, Hu Weiguo, Song Qibin. Therapy for non-small cell lung cancer patients with solitary bone metastases [J]. Journal of International Oncology, 2017, 44(1): 60-62.
[15]	Xiong Ting, Li Liding, Yan Xin, Xie Feiyan, Liao Caiqin, Lu Kaiqiang, Liu Xiaowang, Tu Jian. The mechanism of Genistein in the genesis and development of malignant tumor [J]. Journal of International Oncology, 2016, 43(8): 609-611.